Invention Grant
US08173596B2 Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis
失效
源鸟嘌呤蛋白，以及衍生自其的合成类似物或蛋白水解切割产物，作为涉及盐和/或流体稳态的疾病的治疗和诊断剂
- Patent Title: Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis
- Patent Title (中): 源鸟嘌呤蛋白，以及衍生自其的合成类似物或蛋白水解切割产物，作为涉及盐和/或流体稳态的疾病的治疗和诊断剂
-
Application No.: US11596493Application Date: 2005-05-16
-
Publication No.: US08173596B2Publication Date: 2012-05-08
- Inventor: Michael F. Goy , Nicholas G. Moss , Xun Qian
- Applicant: Michael F. Goy , Nicholas G. Moss , Xun Qian
- Applicant Address: US NC Chapel Hill
- Assignee: The University of North Carolina at Chapel Hill
- Current Assignee: The University of North Carolina at Chapel Hill
- Current Assignee Address: US NC Chapel Hill
- Agency: Jenkins, Wilson, Taylor & Hunt, P.A.
- International Application: PCT/US2005/016937 WO 20050516
- International Announcement: WO2006/001931 WO 20060105
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61P9/00 ; A61P9/12 ; A61P7/10
Abstract:
A method for treating a disorder characterized by salt retention, fluid retention, and combinations thereof. A method for determining the presence of or the progression of a disorder characterized by salt retention, fluid retention, salt loss, fluid loss, and combinations thereof. An immunoassay kit for detecting a level of prouroguanylin in a sample.
Public/Granted literature
Information query
IPC分类:
